UPDATE 1-AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study
January 18, 2019 at 17:45 PM EST
AbbVie Inc said on Friday its blockbuster cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer.
